Zanubrutinib
Acalabrutinib
Obinutuzumab
(Update) Acalabrutinib in CLL and MCL
Update Venetoclax in CLL
CLL Society
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL
Patient Power
ASH: COVID-19 Resources for Managing Blood Cancers